Skip to content
NVIDIA Partners
Wara Samar

15th January 2025

NVIDIA Teams Up with Healthcare Leaders to Advance AI-Driven Medical Innovation

At the JP Morgan Healthcare Conference on January 13, NVIDIA unveiled strategic collaborations with IQVIA, Illumina, Mayo Clinic, and Arc Institute. These partnerships aim to reshape the $10 trillion healthcare and life sciences industry by leveraging agentic and generative AI to accelerate drug discovery, advance genomic research, and enhance healthcare services.

The integration of AI, accelerated computing, and biological data is positioning healthcare as the largest technology-driven industry. With NVIDIA’s cutting-edge solutions, these prominent organizations are pioneering advancements to improve human health.

Transforming Healthcare Operations With AI

NVIDIA’s collaborations focus on three primary AI-driven innovations:

  • AI Agents: Streamlining clinical trials by reducing administrative burdens. 
  • AI Instruments: Enabling breakthroughs in drug discovery and digital pathology through enhanced biological analysis. 
  • AI Robots: Improving surgical precision, patient monitoring, and healthcare operations.

IQVIA: Accelerating Drug Development With AI

Global healthcare intelligence leader IQVIA is utilizing NVIDIA’s AI Foundry service to create tailored foundational AI models. By combining over 64 petabytes of clinical and healthcare data with NVIDIA’s advanced software, IQVIA is developing agentic AI solutions to accelerate research, clinical development, and treatment access. Equipped with NVIDIA AI Enterprise software, including NVIDIA NIM™ microservices and NVIDIA Blueprints, IQVIA ensures its AI tools uphold privacy, regulatory compliance, and patient safety. This collaboration positions IQVIA at the forefront of responsible AI innovation in healthcare.

Illumina and NVIDIA: Driving Genomic Breakthroughs

Illumina, a leader in DNA sequencing and informatics, is working with NVIDIA to revolutionize genomics. This partnership integrates NVIDIA’s accelerated computing and AI technologies into Illumina’s multiomics analysis workflows, making genomic data analysis more accessible to researchers and pharmaceutical companies. 

Key initiatives include offering Illumina’s DRAGEN analysis software on NVIDIA’s computing platform globally. This move will accelerate advancements in target identification, clinical development, and biomarker discovery. Additionally, the partnership integrates NVIDIA’s BioNeMo™ generative AI models and MONAI workflows for spatial cell imaging into Illumina’s Connected Analytics platform.

Mayo Clinic: Redefining Digital Pathology With AI

Mayo Clinic is collaborating with NVIDIA to accelerate the development of AI-powered digital pathology. Leveraging its extensive dataset of 20 million whole-slide images linked to 10 million patient records, Mayo Clinic is creating pathology foundation models to improve cancer diagnosis and treatment. 

NVIDIA’s DGX™ Blackwell systems and MONAI imaging platform will support this endeavor, providing the computational power needed to analyze complex datasets. This partnership aims to transform pathology into a cornerstone for personalized medicine, predictive diagnostics, and efficient treatment strategies. 

Arc Institute: Advancing Biomedical Research with Open AI Models 

Palo Alto-based Arc Institute is joining forces with NVIDIA to develop scalable AI models for biomedical discovery. The collaboration focuses on creating foundational models that generalize across biological modalities like DNA, RNA, and proteins, driving innovations in drug discovery, synthetic biology, and disease research.

With NVIDIA’s BioNeMo platform and expertise in large-scale AI model development, Arc Institute is advancing open science initiatives to share AI tools and discoveries with the global research community.

NVIDIA’s partnerships with IQVIA, Illumina, Mayo Clinic, and Arc Institute demonstrate the transformative potential of AI in healthcare. By addressing critical challenges in drug discovery, genomic research, and clinical operations, these collaborations pave the way for a new era of innovation, improving outcomes for patients and researchers alike.

Explore MedTech World Events

Join the global conversation on MedTech! From MedTech World Dubai 2025 to international roadshows and the signature MedTech Malta 2025, our events connect industry leaders, innovators, and trailblazers. Experience unmatched networking opportunities, expert-led panels, and insightful discussions. Discover our upcoming events and reserve your place to stay ahead in MedTech innovation.

MedTech Dubai 2025

Also Read: NVIDIA Acquires VinBrain – Accelerating AI in Healthcare